Skip to content
lifestyle.travelshq.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AbbVie Inc.
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
January 20, 2026
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
January 8, 2026
AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
←
Previous Page
1
…
3
4
5